Prof. Dr. Florian Haller

Professur für Diagnostische Molekularpathologie

Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019) Weyerer V, Weisser R, Moskalev E, Haller F, Stöhr R, Eckstein M, Zinnall U, et al. Journal article Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) (2019) Eckstein M, Hartmann A, Strissel P, Strick R, Wach S, Taubert H, Wullich B, et al. Conference contribution Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019) Weyerer V, Weisser R, Moskalev E, Haller F, Stoehr R, Eckstein M, Zinnall U, et al. Journal article Tumour mutational burden analysis: implementation in routine diagnostics (2019) Kroeze L, Kamping E, Von Rhein D, Jansen E, De Voer R, Barberis M, Botling J, et al. Conference contribution Frequency of GNAS mutation in intramuscular myxoma (2019) Erber R, Stöhr R, Haller F, Hartmann A, Agaimy A Conference contribution Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands (2019) Haller F, Skálová A, Ihrler S, Märkl B, Bieg M, Moskalev E, Erber R, et al. Journal article First Presentation of idiopathic Mast Cell Activation Syndrome (MCAS) in a Young Person: Association with Histamine and Salicylate Intolerance as well as an important Differential Diagnosis in gastroenterological Problem Patients (2019) Raithel M, Rechenauer T, Goetze T, Siebenlist G, Rueckel A, Baenkler HW, Hartmann A, et al. Conference contribution Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms (2019) Martinez AP, Fritchie KJ, Weiss SW, Agaimy A, Haller F, Huang HY, Lee S, et al. Journal article Successful targeting of BRAF V600E mutation with vemurafenib in a treatment-resistant extragonadal non-seminomatous germ cell tumor (2019) Meintker L, Haller F, Tögel L, Schmidt D, Waibel H, Mackensen A, Meidenbauer N Conference contribution Report of the working group on molecular pathology Bericht der Arbeitsgemeinschaft Molekularpathologie (2019) Haller F, Lassmann S, Siebolts U Journal article